Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Sikov WM. Lancet Oncol 2025;26:1515-1517.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sikov WM. Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? Lancet Oncol 2025;26:1515-1517.
PMID: 41308666